Published in Biochemistry on July 06, 1993
Simulation of the diffusional association of barnase and barstar. Biophys J (1997) 3.33
Weighted-ensemble Brownian dynamics simulations for protein association reactions. Biophys J (1996) 2.87
Thermodynamics and kinetics of actin filament nucleation. Biophys J (2001) 2.34
Enhancement of protein-protein association rate by interaction potential: accuracy of prediction based on local Boltzmann factor. Biophys J (1997) 1.56
Computer modeling of electrostatic steering and orientational effects in antibody-antigen association. Biophys J (1995) 1.51
Differential influence of dynamic processes on forward and reverse electron transfer across a protein-protein interface. Proc Natl Acad Sci U S A (2005) 1.35
A flavodoxin that is required for enzyme activation: the structure of oxidized flavodoxin from Escherichia coli at 1.8 A resolution. Protein Sci (1997) 1.14
Computational carbohydrate chemistry: what theoretical methods can tell us. Glycoconj J (1998) 1.03
Glycolytic enzyme interactions with yeast and skeletal muscle F-actin. Biophys J (2005) 1.01
Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels. Biophys J (2002) 1.00
Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel. Biophys J (2004) 0.98
NCB5OR is a novel soluble NAD(P)H reductase localized in the endoplasmic reticulum. J Biol Chem (2004) 0.98
Photoinitiated singlet and triplet electron transfer across a redesigned [myoglobin, cytochrome b5] interface. J Am Chem Soc (2010) 0.98
Brownian dynamics simulations of interactions between aldolase and G- or F-actin. Biophys J (1999) 0.98
Brownian dynamics simulations of interaction between scorpion toxin Lq2 and potassium ion channel. Biophys J (2001) 0.95
The orientations of cytochrome c in the highly dynamic complex with cytochrome b5 visualized by NMR and docking using HADDOCK. Protein Sci (2005) 0.94
Robust biased Brownian dynamics for rate constant calculation. Biophys J (2003) 0.93
N epsilon,N epsilon-dimethyl-lysine cytochrome c as an NMR probe for lysine involvement in protein-protein complex formation. Biochem J (1998) 0.91
Interfacial hydration, dynamics and electron transfer: multi-scale ET modeling of the transient [myoglobin, cytochrome b5] complex. Phys Chem Chem Phys (2012) 0.90
Electrostatic redesign of the [myoglobin, cytochrome b5] interface to create a well-defined docked complex with rapid interprotein electron transfer. J Am Chem Soc (2009) 0.88
Brownian dynamics simulations of the interaction of Chlamydomonas cytochrome f with plastocyanin and cytochrome c6. Biophys J (2003) 0.86
Electron transfer interactome of cytochrome C. PLoS Comput Biol (2012) 0.85
Evolving the [myoglobin, cytochrome b(5)] complex from dynamic toward simple docking: charging the electron transfer reactive patch. Biochemistry (2012) 0.85
Brownian dynamics study of cytochrome f interactions with cytochrome c6 and plastocyanin in Chlamydomonas reinhardtii plastocyanin, and cytochrome c6 mutants. Biophys J (2004) 0.84
Brownian dynamics simulations of aldolase binding glyceraldehyde 3-phosphate dehydrogenase and the possibility of substrate channeling. Biophys J (2001) 0.83
Electrostatic interactions in the binding pathway of a transient protein complex studied by NMR and isothermal titration calorimetry. J Biol Chem (2014) 0.82
Electron transfer from Phanerochaete chrysosporium cellobiose oxidase to equine cytochrome c and Pseudomonas aeruginosa cytochrome c-551. Biochem J (1994) 0.82
Ionic strength dependence of F-actin and glycolytic enzyme associations: a Brownian dynamics simulations approach. Proteins (2011) 0.82
Modeling dimerizations of transmembrane proteins using Brownian dynamics simulations. J Comput Aided Mol Des (2008) 0.81
Characterization and calculation of a cytochrome c-cytochrome b5 complex using NMR data. Biochemistry (2005) 0.81
A Brownian dynamics study of the interactions of the luminal domains of the cytochrome b6f complex with plastocyanin and cytochrome c6: the effects of the Rieske FeS protein on the interactions. Biophys J (2006) 0.81
Replacements in a conserved leucine cluster in the hydrophobic heme pocket of cytochrome c. Protein Sci (1995) 0.80
Effects of charged amino-acid mutation on the solution structure of cytochrome b(5) and binding between cytochrome b(5) and cytochrome c. Protein Sci (2001) 0.80
A further investigation of the cytochrome b5-cytochrome c complex. J Biol Inorg Chem (2003) 0.80
A Brownian dynamics study of the interaction of Phormidium laminosum plastocyanin with Phormidium laminosum cytochrome f. Biophys J (2004) 0.80
A Brownian dynamics study of the effects of cytochrome f structure and deletion of its small domain in interactions with cytochrome c6 and plastocyanin in Chlamydomonas reinhardtii. Biophys J (2005) 0.79
Protein-protein diffusional encounter. Biophys J (1997) 0.79
Cloning, expression and physicochemical characterization of a di-heme cytochrome c (4) from the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC 125. J Biol Inorg Chem (2008) 0.78
Predicting protein interactions by Brownian dynamics simulations. J Biomed Biotechnol (2012) 0.77
BD SIMULATIONS OF THE IONIC STRENGTH DEPENDENCE OF THE INTERACTIONS BETWEEN TRIOSE PHOSPHATE ISOMERASE AND F-ACTIN. J Undergrad Chem Res (2010) 0.76
Cytochrome c adducts with PCB quinoid metabolites. Environ Sci Pollut Res Int (2015) 0.75
A Brownian dynamics study of the interaction of Phormidium cytochrome f with various cyanobacterial plastocyanins. Biophys J (2005) 0.75
Kinetics of protein-protein association explained by Brownian dynamics computer simulation. Proc Natl Acad Sci U S A (1992) 6.71
Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell (1989) 6.62
Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14
An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV. EMBO J (1987) 3.66
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Ribosomal pausing during translation of an RNA pseudoknot. Mol Cell Biol (1993) 2.81
Brownian dynamics of cytochrome c and cytochrome c peroxidase association. Science (1988) 2.78
The mutation rate and variability of eukaryotic viruses: an analytical review. J Gen Virol (1987) 2.77
Crystal structure of the biphenyl-cleaving extradiol dioxygenase from a PCB-degrading pseudomonad. Science (1995) 2.68
Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65
Mutational analysis of the "slippery-sequence" component of a coronavirus ribosomal frameshifting signal. J Mol Biol (1992) 2.64
Polypeptides specified by the influenza virus genoma. 2. Assignement of protein coding functions to individual genome segments by in vitro translation. Virology (1977) 2.64
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet (1996) 2.59
Mutational analysis of the RNA pseudoknot component of a coronavirus ribosomal frameshifting signal. J Mol Biol (1991) 2.49
The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc Natl Acad Sci U S A (1979) 2.32
CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18
Genetic analysis of a Pseudomonas locus encoding a pathway for biphenyl/polychlorinated biphenyl degradation. Gene (1993) 2.15
Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07
Bacterial expression of a mitochondrial cytochrome c. Trimethylation of lys72 in yeast iso-1-cytochrome c and the alkaline conformational transition. Biochemistry (1998) 2.01
Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96
Complex formation between influenza virus polymerase proteins expressed in Xenopus oocytes. Virology (1989) 1.92
Nucleotide sequence of fowl plague virus RNA segment 7. J Gen Virol (1982) 1.65
Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61
Analysis of three 2,3-dihydroxybiphenyl 1,2-dioxygenases found in Rhodococcus globerulus P6. Identification of a new family of extradiol dioxygenases. J Biol Chem (1994) 1.56
Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol (1997) 1.55
N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52
Determinants of cytochrome c pro-apoptotic activity. The role of lysine 72 trimethylation. J Biol Chem (2000) 1.50
Association of the infectious bronchitis virus 3c protein with the virion envelope. Virology (1991) 1.44
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis (1997) 1.44
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44
Two independently regulated cytochromes P-450 in a Rhodococcus rhodochrous strain that degrades 2-ethoxyphenol and 4-methoxybenzoate. J Bacteriol (1993) 1.42
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41
Site-directed mutagenesis of cytochrome c shows that an invariant Phe is not essential for function. Nature (1985) 1.41
A cluster exposed: structure of the Rieske ferredoxin from biphenyl dioxygenase and the redox properties of Rieske Fe-S proteins. Structure (2000) 1.41
Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40
Reduction of horse heart ferricytochrome c by bovine liver ferrocytochrome b5. Experimental and theoretical analysis. Biochemistry (1991) 1.37
Characterization of 2,2',3-trihydroxybiphenyl dioxygenase, an extradiol dioxygenase from the dibenzofuran- and dibenzo-p-dioxin-degrading bacterium Sphingomonas sp. strain RW1. J Bacteriol (1993) 1.37
Genetic and genomic insights into the role of benzoate-catabolic pathway redundancy in Burkholderia xenovorans LB400. Appl Environ Microbiol (2006) 1.35
Replacement of cysteine-107 of Saccharomyces cerevisiae iso-1-cytochrome c with threonine: improved stability of the mutant protein. Protein Eng (1989) 1.35
Internal entry of ribosomes on a tricistronic mRNA encoded by infectious bronchitis virus. J Virol (1992) 1.34
Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34
A polycistronic mRNA specified by the coronavirus infectious bronchitis virus. Virology (1991) 1.32
A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Polypeptides specified by the influenza virus genome. 3. Control of synthesis in infected cells. Virology (1979) 1.31
Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J Infect Dis (1994) 1.31
Molecular basis for the stabilization and inhibition of 2, 3-dihydroxybiphenyl 1,2-dioxygenase by t-butanol. J Biol Chem (1998) 1.30
Growth substrate- and phase-specific expression of biphenyl, benzoate, and C1 metabolic pathways in Burkholderia xenovorans LB400. J Bacteriol (2005) 1.30
Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30
Replacement of the proximal histidine iron ligand by a cysteine or tyrosine converts heme oxygenase to an oxidase. Biochemistry (1999) 1.29
ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28
Transmutation of a heme protein. Proc Natl Acad Sci U S A (1993) 1.25
A myoglobin variant with a polar substitution in a conserved hydrophobic cluster in the heme binding pocket. Biochim Biophys Acta (1997) 1.25
Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25
Inhibition of the influenza virus RNA-dependent RNA polymerase by antisera directed against the carboxy-terminal region of the PB2 subunit. J Gen Virol (1996) 1.24
Identification of a serine hydrolase as a key determinant in the microbial degradation of polychlorinated biphenyls. J Biol Chem (2000) 1.23
Potentiometric analysis of the flavin cofactors of neuronal nitric oxide synthase. Biochemistry (1999) 1.22
Steady-state kinetic characterization and crystallization of a polychlorinated biphenyl-transforming dioxygenase. J Biol Chem (2000) 1.21
Modulation of the activities of catalase-peroxidase HPI of Escherichia coli by site-directed mutagenesis. Biochemistry (2000) 1.19
Regulated production of an influenza virus spliced mRNA mediated by virus-specific products. EMBO J (1985) 1.18
Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17
Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16
Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16
All in the family: structural and evolutionary relationships among three modular proteins with diverse functions and variable assembly. Protein Sci (1998) 1.14
Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12
Proton linkage in formation of the cytochrome c-cytochrome c peroxidase complex: electrostatic properties of the high- and low-affinity cytochrome binding sites on the peroxidase. Biochemistry (1994) 1.12
Brownian dynamics simulation of protein association. J Comput Aided Mol Des (1988) 1.11
Spliced and unspliced RNAs encoded by virion RNA segment 7 of influenza virus. Nucleic Acids Res (1981) 1.11
Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11
Dissociation of heme from myoglobin and cytochrome b5: comparison of behavior in solution and the gas phase. Biochemistry (1997) 1.09
Safe use of hepatic allografts from donors older than 70 years. Transplantation (1996) 1.09
Role of arginine-38 in regulation of the cytochrome c oxidation-reduction equilibrium. Biochemistry (1989) 1.08
Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08
Differences in the control of virus mRNA splicing during permissive or abortive infection with influenza A (fowl plague) virus. J Gen Virol (1984) 1.07
Relationship between the messenger RNAs transcribed from two overlapping genes of influenza virus. Nucleic Acids Res (1980) 1.06
Liver resection under total vascular isolation. Variations on a theme. Ann Surg (1993) 1.06
Structural studies on yeast nucleosomes. Can J Biochem (1982) 1.06
Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine (1995) 1.05
The role of a conserved internal water molecule and its associated hydrogen bond network in cytochrome c. J Mol Biol (1994) 1.05
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05
The peroxidase activity of a hemin--DNA oligonucleotide complex: free radical damage to specific guanine bases of the DNA. J Am Chem Soc (2001) 1.04
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03
A binding site for activation by the Bacillus subtilis AhrC protein, a repressor/activator of arginine metabolism. Mol Gen Genet (1995) 1.03
Spectrophotometric analysis of the interaction between cytochrome b5 and cytochrome c. Biochemistry (1982) 1.02
Mutagenic, electrochemical, and crystallographic investigation of the cytochrome b5 oxidation-reduction equilibrium: involvement of asparagine-57, serine-64, and heme propionate-7. Biochemistry (1990) 1.01
The solution structure of oxidized Escherichia coli cytochrome b562. Biochemistry (1999) 1.01
Redesign of the interior hydrophilic region of mitochondrial cytochrome c by site-directed mutagenesis. Biochemistry (1993) 1.00
Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer. Vaccine (1996) 1.00
Identification of a new membrane-associated polypeptide specified by the coronavirus infectious bronchitis virus. J Gen Virol (1990) 1.00
A simple new formula to assess liver weight. Transplant Proc (2003) 0.98
Comparative specificities of two evolutionarily divergent hydrolases involved in microbial degradation of polychlorinated biphenyls. J Bacteriol (2001) 0.98
Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res (1999) 0.98
Adult living donor liver transplantation: the hepatologist's perspective. Hepatology (2001) 0.98
Amino acid substitutions at tryptophan-51 of cytochrome c peroxidase: effects on coordination, species preference for cytochrome c, and electron transfer. Biochemistry (1991) 0.98
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant (2010) 0.98
Brownian dynamics simulations of interactions between aldolase and G- or F-actin. Biophys J (1999) 0.98